DOCS Quote, Financials, Valuation and Earnings

DarioHealth Corp. has a net margin of 33.27% compared to Doximity, Inc.'s net margin of -41.48%. Doximity, Inc.'s return on equity of 22.96% beat DarioHealth Corp.'s return on equity of -41.55%.

Doximity, Inc. has a consensus price target of $40.19, signalling upside risk potential of 60.63%. On the other hand DarioHealth Corp. has an analysts' consensus of $18.00 which suggests that it could grow by 53.58%. Given that Doximity, Inc. has higher upside potential than DarioHealth Corp., analysts believe Doximity, Inc. is more attractive than DarioHealth Corp..

Doximity, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth Corp. has a beta of 1.161, suggesting its more volatile than the S&P 500 by 16.051%.

Doximity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity, Inc. pays -- of its earnings as a dividend. DarioHealth Corp. pays out -- of its earnings as a dividend.

Doximity, Inc. quarterly revenues are $185.1M, which are larger than DarioHealth Corp. quarterly revenues of $5M. Doximity, Inc.'s net income of $61.6M is higher than DarioHealth Corp.'s net income of -$2.1M. Notably, Doximity, Inc.'s price-to-earnings ratio is 21.01x while DarioHealth Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity, Inc. is 7.89x versus 6.51x for DarioHealth Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Mitesco, Inc. has a net margin of 33.27% compared to Doximity, Inc.'s net margin of -106766.67%. Doximity, Inc.'s return on equity of 22.96% beat Mitesco, Inc.'s return on equity of --.

Doximity, Inc. has a consensus price target of $40.19, signalling upside risk potential of 60.63%. On the other hand Mitesco, Inc. has an analysts' consensus of -- which suggests that it could grow by 303.67%. Given that Mitesco, Inc. has higher upside potential than Doximity, Inc., analysts believe Mitesco, Inc. is more attractive than Doximity, Inc..

Doximity, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Mitesco, Inc. has a beta of 5.563, suggesting its more volatile than the S&P 500 by 456.284%.

Doximity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Mitesco, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity, Inc. pays -- of its earnings as a dividend. Mitesco, Inc. pays out -- of its earnings as a dividend.

Doximity, Inc. quarterly revenues are $185.1M, which are larger than Mitesco, Inc. quarterly revenues of $3K. Doximity, Inc.'s net income of $61.6M is higher than Mitesco, Inc.'s net income of -$3.2M. Notably, Doximity, Inc.'s price-to-earnings ratio is 21.01x while Mitesco, Inc.'s PE ratio is 2.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity, Inc. is 7.89x versus 24.92x for Mitesco, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Spok Holdings, Inc. has a net margin of 33.27% compared to Doximity, Inc.'s net margin of 9.46%. Doximity, Inc.'s return on equity of 22.96% beat Spok Holdings, Inc.'s return on equity of 10.88%.

Doximity, Inc. has a consensus price target of $40.19, signalling upside risk potential of 60.63%. On the other hand Spok Holdings, Inc. has an analysts' consensus of $20.00 which suggests that it could grow by 53.06%. Given that Doximity, Inc. has higher upside potential than Spok Holdings, Inc., analysts believe Doximity, Inc. is more attractive than Spok Holdings, Inc..

Doximity, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings, Inc. has a beta of 0.415, suggesting its less volatile than the S&P 500 by 58.512%.

Doximity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings, Inc. offers a yield of 9.11% to investors and pays a quarterly dividend of $0.31 per share. Doximity, Inc. pays -- of its earnings as a dividend. Spok Holdings, Inc. pays out 171.77% of its earnings as a dividend.

Doximity, Inc. quarterly revenues are $185.1M, which are larger than Spok Holdings, Inc. quarterly revenues of $33.9M. Doximity, Inc.'s net income of $61.6M is higher than Spok Holdings, Inc.'s net income of $3.2M. Notably, Doximity, Inc.'s price-to-earnings ratio is 21.01x while Spok Holdings, Inc.'s PE ratio is 17.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity, Inc. is 7.89x versus 2.04x for Spok Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Vaso Corp. has a net margin of 33.27% compared to Doximity, Inc.'s net margin of 7.55%. Doximity, Inc.'s return on equity of 22.96% beat Vaso Corp.'s return on equity of 9.61%.

Doximity, Inc. has a consensus price target of $40.19, signalling upside risk potential of 60.63%. On the other hand Vaso Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Doximity, Inc. has higher upside potential than Vaso Corp., analysts believe Doximity, Inc. is more attractive than Vaso Corp..

Doximity, Inc. has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Vaso Corp. has a beta of 0.466, suggesting its less volatile than the S&P 500 by 53.413%.

Doximity, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Vaso Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Doximity, Inc. pays -- of its earnings as a dividend. Vaso Corp. pays out -- of its earnings as a dividend.

Doximity, Inc. quarterly revenues are $185.1M, which are larger than Vaso Corp. quarterly revenues of $22.7M. Doximity, Inc.'s net income of $61.6M is higher than Vaso Corp.'s net income of $1.7M. Notably, Doximity, Inc.'s price-to-earnings ratio is 21.01x while Vaso Corp.'s PE ratio is 12.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Doximity, Inc. is 7.89x versus 0.36x for Vaso Corp.. Usually stocks with elevated PS ratios are considered overvalued.